Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantDC
Durable Capital Partners
Activity from announced rounds
Activity in this selectionAI
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $2.2B 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionBaseten
Builds systems software for AI applications, powering inference and multi-model strategies
$1.5BSeries F
Role not disclosedParloa
Provides AI agents for enterprise customer experience
$350MSeries D
Role not disclosedVieCure
Provides intelligent software platforms for oncology care
$43MUndisclosed
Role not disclosed